Menarini was founded in 1886.In 1915 its headquarters were established in Florence.

1

1964 Opening of Laboratorios Menarini in Barcelona, Spain. This was the beginning of Menarini's internationalisation.

1978 Menarini's Research & Development

was set up at the same time patent legislation for pharmaceutical products was introduced.

1992 With the acquisition of Berlin-Chemie, Menarini entered the markets of Central and Eastern Europe.

Milestones

2

2011 Acquisition of Invida Group, with companiescovering 13 Asia-Pacific countries, nownamed Menarini Asia-Pacific.

2003 Inauguration of Menarini Biotech, anItalian biotechnological company thatcan research, develop and manufacturebiotech pharmaceutical products from the laboratory phase up to production for themarket.

2016 Founding of Vaxynethic, a joint venture company dedicated to the research of innovative technologies for vaccines manufacturing.

Acquisition of CellSearch, a U.S.Company developing advanced technologies for cancer diagnostics.

2013 Acquisition of Silicon Biosystems,

a technology start-up for diagnostics from

liquid biopsies.

113

794

1,306

1,869

2,627

1964 1978 1992 2000 2004 2008

3

2016

3,527

2010

3,031

3,667

20182014

3,296

Consolidated turnover(Million euro)

Source: internal data

Consolidated turnover (Year 2018)

Source: internal data

TURNOVER PER BUSINESS AREA

DOMESTIC/INTERNATIONAL TURNOVER

Other 1%

Pharmaceutical 93%

Diagnostics 6%

Italy 25%

Abroad 75%

4

Menarini in Europe

Sweden: Menarini Diagnostics presence

5

Menarini in the world

The Menarini Group is present with its affiliates, distributors and franchises

in 136 countries worldwide.

6

Asia-Pacific Region

• 2018 turnover over 400 Million Euro

• 3,293 employees

• Direct presence: Singapore (headquarters), China, India, Australia, South Korea, Taiwan, Thailand, the Philippines, Indonesia, Vietnam, New Zealand, Hong Kong and Malaysia.

7

Source: internal data

8

1 Lithuania, Latvia, Estonia2 Honduras, Nicaragua, El Salvador, Guatemala, Panama, Costa Rica

Menarini is leader in many Countries(Year 2018)

Source: IQVIA WRP Q4 2018; °Local IQIVIA Dec18; °°PHARMASTAND Dec18

RANK

Italy 1

Uzbekistan° 1

Moldova° 1

Armenia° 1

Azerbaijan° 1

Georgia° 1

Baltic States (1) 3

Kyrgyzstan° 4

C. America (2) 6

Ukraine°° 6

Kazakhstan 7

Russia 9

Bulgaria 10

Belarus 10

Greece 11

Bosnia & H. 12

Poland 12

Romania 13

Croatia 13

Czech 14

Germany 15

Turkey 15

RANK

Spain 16

Hungary 16

Portugal 18

Serbia 20

Slovakia 20

Philippines 20

Luxembourg 21

Belgium 25

Ireland 25

Austria 26

Lebanon 26

Dominican Rep 27

Singapore 28

Slovenia 28

France 31

Thailand 31

Tunisia 31

Malaysia 33

Uk 34

Switzerland 37

Vietnam 39

Hong Kong 41

2016

16,722

201020082004200019901964

12,89012,584

11,170

7,954

3,606

188

9

1994

5,225

17,640

20182014

16,457

Number of employees

Source: internal data

Employees - % of graduates and technicians

1964 1990 2014

10%

72%91%

10

2018

16 production plantsIn 2018 these plants produced 585 million packs of pharmaceuticals products.

Italy

Pisa, Florence (2 centres),

L'Aquila, Lomagna (Lecco),

Casaletto Lodigiano (Lodi)

Germany Berlin (2 centres), Dresden

Spain Barcelona

Ireland Shannon

Russia Kaluga*

Turkey Istanbul*

Central America Guatemala City*

Indonesia Jakarta*

USA Philadelphia (Huntingdon Valley)**

11

** Diagnostic production* Plants dedicated to production for local markets

Research & Development Centres

12

1978 11 employees in Menarini R&D in Florence

2018 920 employees in Menarini R&D

PISA

FLORENCE

ROMEBARCELONA

BERLIN

BOLOGNA

SINGAPORE